Peach C, Edgington-Mitchell L, Bunnett N, Schmidt B
Physiol Rev. 2022; 103(1):717-785.
PMID: 35901239
PMC: 9662810.
DOI: 10.1152/physrev.00044.2021.
Lin S, Xu H, Pang M, Zhou X, Pan Y, Zhang L
Front Oncol. 2022; 12:831268.
PMID: 35480112
PMC: 9035874.
DOI: 10.3389/fonc.2022.831268.
Lin B, Zhou X, Lin S, Wang X, Zhang M, Cao B
J Mol Med (Berl). 2017; 95(11):1237-1249.
PMID: 28844099
PMC: 8171496.
DOI: 10.1007/s00109-017-1578-5.
Cohen I, Kayode O, Hockla A, Sankaran B, Radisky D, Radisky E
Biochem J. 2016; 473(10):1329-41.
PMID: 26957636
PMC: 4898653.
DOI: 10.1042/BJ20151410.
Ghilardi C, Silini A, Figini S, Anastasia A, Lupi M, Fruscio R
Oncotarget. 2015; 6(29):28389-400.
PMID: 26318044
PMC: 4695067.
DOI: 10.18632/oncotarget.4949.
Sequence and conformational specificity in substrate recognition: several human Kunitz protease inhibitor domains are specific substrates of mesotrypsin.
Pendlebury D, Wang R, Henin R, Hockla A, Soares A, Madden B
J Biol Chem. 2014; 289(47):32783-97.
PMID: 25301953
PMC: 4239628.
DOI: 10.1074/jbc.M114.609560.
Proteolytic activation of the human epithelial sodium channel by trypsin IV and trypsin I involves distinct cleavage sites.
Haerteis S, Krappitz A, Krappitz M, Murphy J, Bertog M, Krueger B
J Biol Chem. 2014; 289(27):19067-78.
PMID: 24841206
PMC: 4081944.
DOI: 10.1074/jbc.M113.538470.
Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants.
Cattaruzza F, Amadesi S, Carlsson J, Murphy J, Lyo V, Kirkwood K
Br J Pharmacol. 2014; 171(16):3814-26.
PMID: 24749982
PMC: 4128045.
DOI: 10.1111/bph.12738.
Biochemical and structural insights into mesotrypsin: an unusual human trypsin.
Salameh M, Radisky E
Int J Biochem Mol Biol. 2013; 4(3):129-39.
PMID: 24049668
PMC: 3776145.
PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer.
Hockla A, Miller E, Salameh M, Copland J, Radisky D, Radisky E
Mol Cancer Res. 2012; 10(12):1555-66.
PMID: 23258495
PMC: 3531873.
DOI: 10.1158/1541-7786.MCR-12-0314.
The P(2)' residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity.
Salameh M, Soares A, Hockla A, Radisky D, Radisky E
Biochem J. 2011; 440(1):95-105.
PMID: 21806544
PMC: 3380622.
DOI: 10.1042/BJ20110788.
Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior.
Almonte A, Sweatt J
Brain Res. 2011; 1407:107-22.
PMID: 21782155
PMC: 3148282.
DOI: 10.1016/j.brainres.2011.06.042.
Serine proteases mediate inflammatory pain in acute pancreatitis.
Ceppa E, Lyo V, Grady E, Knecht W, Grahn S, Peterson A
Am J Physiol Gastrointest Liver Physiol. 2011; 300(6):G1033-42.
PMID: 21436316
PMC: 3774216.
DOI: 10.1152/ajpgi.00305.2010.
In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study.
Petzold A, Tisdall M, Girbes A, Martinian L, Thom M, Kitchen N
Brain. 2011; 134(Pt 2):464-83.
PMID: 21278408
PMC: 3030768.
DOI: 10.1093/brain/awq360.
Determinants of affinity and proteolytic stability in interactions of Kunitz family protease inhibitors with mesotrypsin.
Salameh M, Soares A, Navaneetham D, Sinha D, Walsh P, Radisky E
J Biol Chem. 2010; 285(47):36884-96.
PMID: 20861008
PMC: 2978618.
DOI: 10.1074/jbc.M110.171348.
The amyloid precursor protein/protease nexin 2 Kunitz inhibitor domain is a highly specific substrate of mesotrypsin.
Salameh M, Robinson J, Navaneetham D, Sinha D, Madden B, Walsh P
J Biol Chem. 2009; 285(3):1939-49.
PMID: 19920152
PMC: 2804352.
DOI: 10.1074/jbc.M109.057216.
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.
Gaber A, Johansson M, Stenman U, Hotakainen K, Ponten F, Glimelius B
Br J Cancer. 2009; 100(10):1540-8.
PMID: 19384300
PMC: 2696764.
DOI: 10.1038/sj.bjc.6605047.
Regional distribution of human trypsinogen 4 in human brain at mRNA and protein level.
Toth J, Siklodi E, Medveczky P, Gallatz K, Nemeth P, Szilagyi L
Neurochem Res. 2007; 32(9):1423-33.
PMID: 17406981
DOI: 10.1007/s11064-007-9327-8.
Activity of recombinant trypsin isoforms on human proteinase-activated receptors (PAR): mesotrypsin cannot activate epithelial PAR-1, -2, but weakly activates brain PAR-1.
Grishina Z, Ostrowska E, Halangk W, Sahin-Toth M, Reiser G
Br J Pharmacol. 2005; 146(7):990-9.
PMID: 16231009
PMC: 1751236.
DOI: 10.1038/sj.bjp.0706410.
Resuscitating mutations in a furin cleavage-deficient mutant of the flavivirus tick-borne encephalitis virus.
Elshuber S, Mandl C
J Virol. 2005; 79(18):11813-23.
PMID: 16140758
PMC: 1212607.
DOI: 10.1128/JVI.79.18.11813-11823.2005.